Rationale for Estrogen With Interrupted Progestin as a New Low-Dose Hormonal Replacement Therapy
- 6 September 1996
- journal article
- research article
- Published by Springer Nature in Journal of the Society for Gynecologic Investigation
- Vol. 3 (5) , 225-234
- https://doi.org/10.1177/107155769600300501
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Lumbar vertebral density and mechanial properties in aged ovariectomized rats treated with estrogen and norethindrone or norgestimateAmerican Journal of Obstetrics and Gynecology, 1995
- Integrated control of cell proliferation and cell death by the c- myc oncogenePhilosophical Transactions Of The Royal Society B-Biological Sciences, 1994
- Phosphorylation and estradiol binding of estrogen receptor in hormone‐dependent and hormone‐independent GR mouse mammary tumorsInternational Journal of Cancer, 1992
- Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cellsBreast Cancer Research and Treatment, 1989
- Rapid recovery of nuclear estrogen receptor and oxytocin receptor in the ovine uterus following progesterone withdrawalJournal of Steroid Biochemistry, 1985
- Progesterone-mediated suppression of estradiol receptors in cynomolgus macaque cervix, endometrium and oviduct during sequential estradiol-progesterone treatmentJournal of Steroid Biochemistry, 1985
- Regulation of estrogen and progesterone receptor levels in epithelium and stroma from pre-and postmenopausal endometriaThe Journal of Steroid Biochemistry and Molecular Biology, 1982
- Effects of Estrogens and Progestins on the Biochemistry and Morphology of the Postmenopausal EndometriumNew England Journal of Medicine, 1981
- Replacement Estrogens and Endometrial CancerNew England Journal of Medicine, 1979
- Glucocorticoid receptors: Relations between steroid binding and biological effectsJournal of Molecular Biology, 1972